Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Submitted by
admin
on August 31, 2012 - 12:34pm
Source:
Yahoo/AP
News Tags:
Pfizer
immune therapy
VLST
CP-870
893
Headline:
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Do Not Allow Advertisers to Use My Personal information
